A new study compares the benefits and risks of taking GLP-1 medications for weight loss, including risks of dementia, ...

For people with diabetes, the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with a reduc ...

Glucagon-like peptide-1 receptor agonists (GLP-1RAs), used to treat diabetes and for weight loss, may be linked with a reduced risk of substance use and neurocognitive disorders, a US study in people ...

The study included nearly 2 million patients, making it the largest ever conducted on this group of glucagon-like peptide-1 ...

With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.

Glucagon-like peptide-1 (GLP-1) analogs also known as incretin mimetics are class of drugs indicated for type-2 diabetes mellitus to lower the blood sugar level Mr. Shah Coherent Market Insights Pvt.

HealthDay News — For patients with diabetes undergoing a surgical procedure, an active perioperative glucagon-like peptide-1 ... Patients with type 1 or type 2 diabetes undergoing a surgical ...

"There was an increased risk of gastrointestinal disorders, hypotension, syncope (low blood pressure), arthritic disorders, ...

Older adults with type 2 diabetes received fewer noninsulin diabetes medications in their final year of life, but insulin use ...

A range of GLP-1 weight loss drugs are currently on the market. What are they, what do they do, and where are they available?

This is the beginning of a revolution, and how you engage and how you attack it is going to really set the stage for your ...

Type 2 diabetes is a chronic condition that affects the body’s ability to regulate blood sugar levels. For many patients, ...